Type III Interferons IL-28 and IL-29: Novel Interferon Family Members with Therapeutic Potential in Cancer Therapy

QR Code

Type III Interferons IL-28 and IL-29: Novel Interferon Family Members with Therapeutic Potential in Cancer Therapy

None

Saved in:

Bibliographic Details
Main Authors:	Fujie, Hitomi, Numasaki, Muneo
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/27452
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Interferons lambda – therapeutic application
by: N. A. Kikhtenko, et al.
Published: (2020-05-01)

The impact of genetic polymorphisms of IL28B gene on the efficacy of antiviral therapy of the chronic hepatitis C by using the standard Interferon-<i>α</i>
by: A. V. Lapshin, et al.
Published: (2013-03-01)

Interferons : an example of communication /
by: Sanders, F. Kingsley (Frank Kingsley)
Published: (1981)

Stimulator of Interferon Genes (STING)-Type I Interferon Signaling: Bridging Immunity and Pain
by: Ti-Chuan Chiu, et al.
Published: (2025-06-01)

Poxvirus Vectors Activate Human NK and MAIT Cells in a Type I Interferon, IL-18, and Monocyte-Dependent Manner
by: Kombo F. N’guessan, et al.
Published: (2025-01-01)

INTERFERONS AND EYE DISEASES
by: N. A. Kikhtenko, et al.
Published: (2019-06-01)

The expression of interferon-stimulated genes (interferon “signature”) in patients with rheumatoid arthritis (Preliminary results)
by: A. S. Avdeeva, et al.
Published: (2021-01-01)

Virus Infection and Type I Interferon in Endometriosis
by: Martensen, Pia M., et al.
Published: (2012)

Interferon, the Cell Cycle and Herpesvirus
by: Costa, H., et al.
Published: (2012)

Interferon-γ and tumor growth
by: A. L. Ilyushin, et al.
Published: (2023-09-01)

Interferon-Gamma: Treatment Horizons
by: A. A. Khryanin, et al.
Published: (2020-05-01)

PECULIARITIES OF THE III TYPE INTERFERON GENES’ POLYMORPHISM IN HCV PATIENTS ON THE CROSS-BORDER REGIONS OF RUSSIA AND MONGOLIA
by: I. V. Malov, et al.
Published: (2017-10-01)

Influence of interferon types on COVID-19 prevention and treatment
by: S. S. Saidov, et al.
Published: (2021-10-01)

Type 1 Interferons: Induction and Mechanisms of Antiviral Action
by: A. N. Vasilyev, et al.
Published: (2020-05-01)

ACTIVATION OF SYNTHESIS OF ENDOGENOUS INTERFERON (REVIEW)
by: V. V. Poloskov, et al.
Published: (2019-01-01)

Interferon and Apoptosis in Systemic Lupus Erythematosus
by: Clark, Daniel N., et al.
Published: (2012)

ADVERSE EVENTS OF INTERFERONS WITH SYSTEMIC EFFECT
by: A. A. Toporov, et al.
Published: (2018-02-01)

The role of cytokines and interferons during pregnancy
by: T. Е. Belokrinitskaya, et al.
Published: (2024-09-01)

DEVELOPMENT OF OPTIMAL EXPERIMENTAL THERAPEUTIC REGIMENS ADMINISTRATION OF IMMOBILIZED INTERFERON α-2b
by: O. G. Shitikova, et al.
Published: (2014-10-01)

Experience with type I interferon inhibitor in systemic lupus erythematosus
by: Ya. A. Leineman, et al.
Published: (2022-08-01)

Induction of Type 1, 2 and 3 Interferons by Acridone Acetates
by: S. S. Grigoryan, et al.
Published: (2020-05-01)

Il III congresso geografico dell'Urss
by: Osvaldo Baldacci
Published: (1960-12-01)

The Role of Hepatitis C Virus NS5A Region Mutation and SNP IL-28B of Host to Support Successful Pegylated Interferon and Ribavirin Treatment in Patients with HCV-HIV Coinfection: A Prospective Cohort Study
by: Juferdy Kurniawan, et al.
Published: (2019-08-01)

The Role of Hepatitis C Virus NS5A Region Mutation and SNP IL-28B of Host to Support Successful Pegylated Interferon and Ribavirin Treatment in Patients with HCV-HIV Coinfection: A Prospective Cohort Study
by: Juferdy Kurniawan, et al.
Published: (2019-08-01)

SYNERGY IN MIXED RIBAVERIN-INTERFERON AQUEOS SOLUTIONS
by: K. Kienskaya, et al.
Published: (2017-09-01)

Prospects for the use of interferon in the treatment of infertility in men
by: S. V. Rishchuk, et al.
Published: (2021-06-01)

ROLE OF INTERFERONS IN REGULATION OF OSTOGENIC AND OSTEORESORPTIVE PROCESSES
by: L. A. Dmitrieva, et al.
Published: (2012-09-01)

The Use of Interferon Inducers in an Infectious Disease Clinic
by: A. A. Shuldyakov, et al.
Published: (2020-05-01)

Virus Infections and Interferon Inductors in the Complex Therapy
by: M. G. Romantsov, et al.
Published: (2020-05-01)

Editorial: Modulation of pro-inflammatory signaling by interferons
by: René Huber, et al.
Published: (2025-07-01)

Interferon Lambda: The Next Frontier in Antiviral Therapy?
by: Sofia Chronopoulou, et al.
Published: (2025-05-01)

Il XVII Congresso Geografico Italiano,Bari 23-29 1957
by: Osvaldo Baldacci
Published: (1957-12-01)

A Novel Microencapsulated Bovine Recombinant Interferon Tau Formulation for Luteolysis Modulation in Cattle
by: Emilio Lamazares, et al.
Published: (2025-07-01)

Age-dependent differences in type I interferon, IL-12 and pro-inflammatory cytokine production by porcine peripheral blood mononuclear cells in response to pseudorabies virus-infected cells
by: Manon S. C. Claeys, et al.
Published: (2025-07-01)

IMMUNOINFLAMMATORY RHEUMATIC DISEASES ASSOCIATED WITH TYPE I INTERFERON: NEW EVIDENCE
by: E. L. Nasonov, et al.
Published: (2019-09-01)

Il terremoto calabro-siculo del 28 dicembre 1908. Messina.
by: Mario Baratta
Published: (1909-12-01)

Il terremoto calabro-siculo del 28 dicembre 1908, Messina.
by: Mario Baratta
Published: (1909-12-01)

Activation of interferon-α signaling by resveratrol, genistein and quercetin
by: O. A. Vlasova, et al.
Published: (2019-02-01)

Problems of interchangeability of systemic interferons for treatment of multiple sclerosis
by: I. I. Snegireva, et al.
Published: (2018-02-01)

Effect of interferon on broilers' fecal microbiome composition
by: Inna Burakova, et al.
Published: (2025-04-01)